Walker Richard Wharton

Title: Walker Richard Wharton: Innovator in Targeted Cancer Therapies

Introduction

Walker Richard Wharton is a notable inventor based in Corrales, NM (US). He has made significant contributions to the field of cancer treatment through his innovative work on protocells. With a total of 2 patents, his research focuses on the targeted delivery of therapeutic agents to cancer cells.

Latest Patents

Wharton's latest patents include groundbreaking work on protocells and their use for targeted delivery of multicomponent cargos to cancer cells. Various embodiments of his inventions provide materials and methods for synthesizing protocells that can effectively deliver cargo components to cancer cells. In one embodiment, the lipid bilayer is fused to a porous particle core to form a protocell. This lipid bilayer can be modified with targeting ligands to achieve precise delivery of the loaded cargo to specific target cells, such as cancer cells. Additionally, shielding materials can be conjugated to the surface of the lipid bilayer to minimize undesired non-specific binding.

Career Highlights

Throughout his career, Walker Richard Wharton has worked with prominent organizations, including Stc.unm and Sandia Corporation. His work in these institutions has allowed him to advance his research and contribute to the development of innovative cancer therapies.

Collaborations

Some of his notable coworkers include C Jeffrey Brinker and Carlee Erin Ashley. Their collaborative efforts have further enhanced the impact of Wharton's research in the field of targeted cancer therapies.

Conclusion

Walker Richard Wharton is a distinguished inventor whose work on protocells has the potential to revolutionize cancer treatment. His innovative approaches to targeted delivery systems demonstrate the importance of research in improving therapeutic outcomes for patients.